Multicenter phase I clinical trial of daily and weekly RAD001 in combination with vinorelbine and trastuzumab in patients with HER2-overexpressing metastatic breast cancer with prior resistance to trastuzumab

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 1057-1057 ◽  
Author(s):  
G. H. Jerusalem ◽  
V. Dieras ◽  
F. Cardoso ◽  
J. Bergh ◽  
A. Fasolo ◽  
...  
2015 ◽  
Vol 4 (7) ◽  
pp. 1051-1059 ◽  
Author(s):  
Pavani Chalasani ◽  
Marilyn Marron ◽  
Denise Roe ◽  
Kathryn Clarke ◽  
Maria Iannone ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document